The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance

Tongguo Shi1, Chuanqiang Zhang2, Suhua Xia3

  • 1Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, 178 East Ganjiang Road, Suzhou, China. shitg@suda.edu.cn.

Insights

Cancer cells resist anoikis, a process crucial for metastasis, making it a therapeutic target. Non-coding RNAs (ncRNAs) like miRNAs, lncRNAs, and circRNAs significantly regulate this resistance, offering new treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Anoikis resistance is a key driver of cancer cell metastasis.
  • This resistance is regulated by signaling pathways, integrin switching, and non-coding RNAs (ncRNAs).
  • ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are often dysregulated in cancers.

Purpose of the Study:

  • To review the molecular mechanisms of ncRNAs in modulating cancer cell anoikis resistance.
  • To enhance understanding of cancer metastasis.
  • To identify potential therapeutic strategies targeting ncRNAs for cancer treatment.

Main Methods:

  • Literature review of existing studies on ncRNAs and anoikis resistance.
  • Analysis of molecular pathways involved in ncRNA-mediated anoikis resistance.
  • Synthesis of current knowledge on the role of miRNAs, lncRNAs, and circRNAs.

Main Results:

  • ncRNAs play a significant role in the development and progression of anoikis resistance in cancer cells.
  • Dysregulation of specific ncRNAs is linked to increased metastatic potential.
  • Understanding these ncRNA roles provides insights into cancer cell survival mechanisms.

Conclusions:

  • ncRNAs are critical regulators of anoikis resistance and cancer metastasis.
  • Targeting ncRNAs presents a promising therapeutic avenue for overcoming cancer metastasis.
  • Further research into ncRNA functions can lead to novel anti-cancer strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K